Moderna Now Testing COVID-19 Vaccine on Adolescents

Moderna has begun testing its coronavirus vaccine on adolescents, the drugmaker announced Thursday as it gears up for U.S distribution upon imminent approval for adult use.

The company said it plans to enroll 3,000 U.S. teenagers and preteens as young as 12 during its trial stages. Each child participant will receive either the coronavirus candidate or a placebo during both vaccinations.

Moderna CEO Stephane Bancel said the company hopes to have data supporting child vaccination in the spring before the 2021 school year starts.

Meanwhile, Pfizer, which has developed along with German partner BioNTech the other vaccine candidate seeking federal approval in the coming days, launched its child testing program in October.

U.S. pediatricians worry they may not know if any of the shots work for young children in time for the next school year, WUSA-TV (Channel 9) reported.

As of Thursday, the U.S. has roughly 15.4 million coronavirus cases and 290,000 deaths — both tops globally — according to a Johns Hopkins University tracker.

Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Back to top button

My News Matters to me - Washington Informer Donations

Be a Part of The Washington Informer Legacy

A donation of your choice empowers our journalists to continue the work to better inform, educate and empower you through technology and resources that you use.

Click Here Today to Support Black Press and be a part of the Legacy!

Adblock Detected

Please consider supporting us by disabling your ad blocker